Rep. Celeste Maloy

Maddy summaryThis bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.

Maddy summaryThis bill expands foreign investment review to cover U.S. agriculture by requiring transactions involving foreign control of agricultural businesses to undergo scrutiny by the Committee on Foreign Investment (CFIUS). It classifies agricultural supply chains as both critical infrastructure and critical technologies, directly affecting foreign entities seeking to acquire or influence U.S. farms, food production, and supply chains. The bill mandates annual reports from the Secretary of Agriculture and the Government Accountability Office on foreign investments in agriculture, including risks to food security and intellectual property. These provisions aim to mitigate potential threats to U.S. food supply chains from foreign adversaries through enhanced oversight.